9:00 am Chair’s Opening Remarks

9:10 am Late Breaking Abstract: Tumor Tissue Mechanisms that Facilitate or Restrict the Activity of Genetically Engineered T Cells

  • Adrian Bot VP, Translational Medicine, Kite, a Gilead Company

9:35 am Late Breaking Abstract: Preclinical & Translational Data Supporting Initiation of the DesCAARTes Phase 1 Trial of DSG3- CAART in Patients with Mucosal-Dominant Pemphigus Vulgaris

  • Samik Basu VP, Translational Immunology, Cabaletta Bio

10:00 am Late Breaking Abstract: Manufacturing Matters in CAR-T: Small Changes Can Have a Big Impact

  • Eric Ostertag Chairman & Chief Executive Officer, Poseida Therapeutics

10:25 am Coffee Networking Chats

CLINICAL MANAGEMENT

Setting Up Effective Infrastructure to Support Trials

11:30 am CAR-T: Continuation in a Revolution of Cancer Therapeutics

  • Joseph McGuirk Director of HMCT, University of Kansas Medical Center

11:50 am Clinical Operations for Cellular Therapies, Lessons Learned in an Academic Setting

  • Alison Holzer-Speed Stem Cell and Gene Therapy Clinical Trials Program Director, Stanford School of Medicine

12:10 pm Medical Monitoring Approach in CAR-T Clinical trials, during the COVID-19 Pandemic and Beyond

  • Carlo Lanza Covance Executive Medical Officer & Subject Matter Expert in Hematology Oncology, Covance

12:30 pm Live Q&A with Your Expert Speakers

  • Joseph McGuirk Director of HMCT, University of Kansas Medical Center
  • Alison Holzer-Speed Stem Cell and Gene Therapy Clinical Trials Program Director, Stanford School of Medicine
  • Carlo Lanza Covance Executive Medical Officer & Subject Matter Expert in Hematology Oncology, Covance

Tech slam

12:45 pm From Vein to Vein: How Starting Material Quality Impacts the Manufacturing and Success of Next-Generation Therapies

  • Tim Tripp Director, Cell and Gene Therapy Operations, Be The Match BioTherapies

12:55 pm Digitizing Workflows and Manufacturing for Stem and Novel Cell Therapies

1:05 pm Advancing QC for Cell and Gene Therapies – From Starting Material to Product Delivery

1:15 pm Refreshment Break

Synopsis

Take this break to follow up with our expert partners and explore the demo area!

Managing Growth Strain on Clinical Settings

1:45 pm Growth in the CAR-TCR Landscape

2:10 pm Delivering Patient-specific Therapies on the NHS

  • Amit Patel Consultant, Cellular Therapies and Stem Cell Transplantation, The Christie NHS

2:35 pm Benchmark Labelling & Processing to Achieve Standardization Across Sites

  • Nicole Aqui Chief, Transfusion and Apheresis Services, University of Pennsylvania

3:00 pm Virtual Speed Networking & Poster Session

4:00 pm Panel Discussion: How to Run CAR-TCR Trials During a Pandemic

Improving Accessibility for Patients Globally

4:40 pm Overcoming Restrictions for Access

5:05 pm Cell & Gene Therapies are Here – Is your Institution Ready?

  • Robert Richards Administrative Director, Cell Therapy & Transplant, University of Pennsylvania

5:30 pm Chair’s Closing Remarks

5:35 pm Post-Conference Networking

Synopsis

Follow up with those you have met online during the conference or join the open networking room to discuss the day with your colleagues.